Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.19B
| $19.2M | ﹤0.01% |
421,570
+109,459
| +35% | +$4.6M |
|
3127
Universal Corp
UVV
$1.14B
| $19.1M | ﹤0.01% |
366,366
+1,961
| +0.5% | +$104K |
|
3128
Monte Rosa Therapeutics
GLUE
$1.14B
| $19.1M | ﹤0.01% |
789,545
+105,482
| +15% | +$1.99M |
|
3129
Alerian Energy Infrastructure ETF
ENFR
$534M
| $19.1M | ﹤0.01% |
500,813
-36,971
| -7% | -$1.41M |
|
3130
Apogee Enterprises
APOG
$842M
| $19.1M | ﹤0.01% |
416,602
+44,351
| +12% | +$1.66M |
|
|
BRUN
3131
Boost Run Inc
BRUN
$1.36B
| $19M | ﹤0.01% |
+490,680
| New | +$15.2M |
|
3132
T. Rowe Price QM US Bond ETF
TAGG
$2.55B
| $19M | ﹤0.01% |
448,396
+58,591
| +15% | +$2.49M |
|
3133
PureCycle Technologies
PCT
$1.31B
| $19M | ﹤0.01% |
2,345,268
-511,856
| -18% | -$4.59M |
|
3134
iShares U.S. Large Cap Premium Income Active ETF
BALI
$1.38B
| $19M | ﹤0.01% |
561,949
+220,127
| +64% | +$7.28M |
|
|
FTF
3135
Franklin Limited Duration Income Trust
FTF
$234M
| $19M | ﹤0.01% |
3,280,091
-110,295
| -3% | -$647K |
|
3136
ADMA Biologics
ADMA
$2.09B
| $19M | ﹤0.01% |
2,265,443
-168,936
| -7% | -$1.54M |
|
3137
State Street SPDR S&P Health Care Equipment ETF
XHE
$176M
| $18.9M | ﹤0.01% |
224,935
+24,418
| +12% | +$1.98M |
|
3138
Invesco S&P 500 BuyWrite ETF
PBP
$376M
| $18.9M | ﹤0.01% |
827,089
+31,725
| +4% | +$718K |
|
3139
S&T Bancorp
STBA
$1.76B
| $18.9M | ﹤0.01% |
384,538
+19,199
| +5% | +$865K |
|
|
GRFS
3140
Grifois
GRFS
$5.23B
| $18.8M | ﹤0.01% |
2,661,180
-196,776
| -7% | -$1.55M |
|
3141
Nuveen ESG Emerging Markets Equity ETF
NUEM
$418M
| $18.8M | ﹤0.01% |
443,927
+4,131
| +0.9% | +$169K |
|
3142
Innospec
IOSP
$2.35B
| $18.8M | ﹤0.01% |
230,793
-4,778
| -2% | -$378K |
|
|
EDD
3143
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$379M
| $18.8M | ﹤0.01% |
3,190,806
+507,411
| +19% | +$2.82M |
|
3144
TRI-Continental Corp
TY
$1.89B
| $18.7M | ﹤0.01% |
543,357
-10,440
| -2% | -$358K |
|
3145
PagerDuty
PD
$1.09B
| $18.7M | ﹤0.01% |
1,937,403
+47,931
| +3% | +$363K |
|
3146
JPMorgan Diversified Return US Small Cap Equity ETF
JPSE
$596M
| $18.6M | ﹤0.01% |
309,893
+37,327
| +14% | +$2.14M |
|
3147
Invesco Taxable Municipal Bond ETF
BAB
$944M
| $18.6M | ﹤0.01% |
694,189
-130,088
| -16% | -$3.49M |
|
|
ECC
3148
Eagle Point Credit Company
ECC
$519M
| $18.6M | ﹤0.01% |
5,003,226
-410,303
| -8% | -$1.64M |
|
3149
USCF SummerHaven Dynamic Commodity Strategy No K-1 Fund
SDCI
$610M
| $18.6M | ﹤0.01% |
702,900
+369,333
| +111% | +$10.2M |
|
3150
NovaGold Resources
NG
$3.84B
| $18.6M | ﹤0.01% |
3,107,689
+230,619
| +8% | +$1.92M |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.